Abcam plc

Headquarters: Cambridge, United Kingdom

Employees: 1,650

CEO: Mr. Alan Thomas Hirzel BS, MBA, MS

LSE: ABC +11.15%

Market Cap

£2.91 Billion

GBP as of Dec. 1, 2022

US$3.58 Billion

Market Cap History

Abcam plc market capitalization over time

Evolution of Abcam plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Abcam plc

Detailed Description

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Top 1-year algo backtest: +207.50%

$10,000 in July 2023 would now be $30,750 by following this algorithm daily at market close.

Boost your returns with Disfold DeepFinance... Now!

Try Disfold DeepFinance FREE



Discovery Drive

Cambridge Biomedical Campus

Cambridge, CB2 0AX

United Kingdom

Phone: 44 1223 696 000

Fax: 44 1223 215 215